AdvanSource Biomaterials Corp
ASB
ASB was delisted on the 23rd of November, 2010.
1 hedge funds and large institutions have $0 invested in AdvanSource Biomaterials Corp in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
100% less capital invested
Capital invested by funds: $12 → $0 (-$12)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$12 |
ASB Hedge Fund Activity: Q1 2015 in Review
1 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in AdvanSource Biomaterials Corp (ASB) for Q1 2015, worth a combined $0 — down 100% from $12 a quarter earlier.
Fund positioning in ASB was balanced in Q1 2015: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was B. Riley Wealth Advisors, exiting entirely with an estimated $12 sold.
- 1 institutional investor held AdvanSource Biomaterials Corp (ASB) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $0 of AdvanSource Biomaterials Corp stock for Q1 2015, down 100% quarter-over-quarter.
- 1 fund opened new AdvanSource Biomaterials Corp positions in Q1 2015 and 1 closed out, a net change of 0 holders.
- The largest AdvanSource Biomaterials Corp seller in Q1 2015 was B. Riley Wealth Advisors, an estimated $12 sold.
Based on aggregated 13F filings for Q1 2015.